FRPT:NASDAQFreshpet, Inc. Analysis
Data as of 2026-05-19 - not real-time
$48.45
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Freshpet, Inc. (FRPT) is trading at $48.45, just above its computed support of $47.81 and well below its 20‑day SMA of $58.83, indicating short‑term price weakness but a potential technical bounce. The RSI of 27.5 signals oversold conditions, while a bearish MACD histogram reinforces downward momentum, yet volume is increasing, suggesting accumulating interest. Fundamentally, the company shows solid top‑line growth of 13% YoY and a healthy profit margin of 17.6%, though operating margins remain thin at 1.5% and free cash flow is modest. The DCF fair value of roughly $4.20 is dramatically lower than the market price, flagging the stock as severely overvalued, while the forward P/E of 25.4 points to muted earnings expectations. Analyst consensus remains a “Buy” with a median target near $80, reflecting optimism about revenue expansion and brand penetration in the refrigerated pet‑food niche. However, recent earnings missed consensus estimates and highlighted profit quality concerns, adding uncertainty to the upside.
Given the high 30‑day volatility (≈58%), a beta under 1, and a consumer‑defensive sector backdrop, risk is moderate. The lack of dividend and a debt‑to‑equity ratio near 39% suggest capital structure pressures, while the company’s geographic exposure is limited to North America and Europe, keeping currency risk low. Overall, the stock presents a mixed picture: technical oversold signals and growth potential counterbalanced by steep valuation gaps and earnings quality doubts.
Given the high 30‑day volatility (≈58%), a beta under 1, and a consumer‑defensive sector backdrop, risk is moderate. The lack of dividend and a debt‑to‑equity ratio near 39% suggest capital structure pressures, while the company’s geographic exposure is limited to North America and Europe, keeping currency risk low. Overall, the stock presents a mixed picture: technical oversold signals and growth potential counterbalanced by steep valuation gaps and earnings quality doubts.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Oversold RSI indicating potential price rebound
- Current price near technical support level
- Increasing volume suggesting accumulation
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Revenue growth and expanding market presence
- Bearish MACD and price below SMA50/200 signaling continued pressure
- Analyst target range implying upside if fundamentals improve
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- DCF fair value far below market price indicating large valuation gap
- Persistent profit margin compression and modest free cash flow
- High volatility and earnings quality concerns reducing confidence
Key Metrics & Analysis
Financial Health
Revenue Growth13.10%
Profit Margin17.63%
P/E Ratio12.7
ROE17.33%
ROA3.41%
Debt/Equity39.15
P/B Ratio1.9
Op. Cash Flow$196.1M
Free Cash Flow$14.2M
Technical Analysis
TrendNeutral
RSI27.5
Support$47.81
Resistance$68.71
MA 20$58.83
MA 50$63.50
MA 200$61.76
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61
Valuation
Fair Value$4.20
Target Price$82.38
Upside/Downside70.02%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.80
Volatility57.74%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.